A government review's six-year-old recommendations led to the decision to fund an unapproved and unapprovable product over an approved medicine. The document is the first in a series that ended with an unprecedented workaround on patient safety and confirms the truism that 'everything happens for a reason'. …
The 'Dispatched' Podcast - 'This draws a line through everything and it's not good'
December 22, 2024 Podcast
Latest Video
New Stories
-
Cartherics appoints Dr Ian Nisbet as CEO as the company accelerates toward clinical trials
December 1, 2025 - - Australian Biotech -
Australian company reports high response rate in trial of off-the-shelf CAR-T therapy
December 1, 2025 - -
Melbourne showcases its health and biomedical strength as leaders gather for National Precincts Summit
December 1, 2025 - - Australian Biotech -
Pharmac to expand emergency medicine access for rural and remote communities
December 1, 2025 - - Latest News -
Tetratherix joint venture secures Alcon partnership to accelerate ophthalmic biomaterials
December 1, 2025 - - Australian Biotech -
MSD to bring vaccine distribution back in-house after 40-year partnership
December 1, 2025 - - Latest News -
New PBS listing offers fresh hope for Australians living with debilitating skin condition
December 1, 2025 - - Latest News